Why Aren't More People Using Medical Cannabis?
Understanding the systemic barriers to evidence-based cannabis therapy
Despite growing evidence supporting medical cannabis efficacy, adoption remains limited. Significant barriers exist for both patients and healthcare providers, preventing widespread access to this therapeutic option.
Why Aren't Cannabis-Based Solutions Offered to Everyone?
Existing Barriers for Patients and Physicians:
Physicians have limited experience and lack training in cannabis, making them hesitant to prescribe it.
Strict regulatory environment deters new players from entering the market.
The Result: Patients struggle to access tailored cannabis treatments, forced to rely on conventional medications.
Key Questions in Cannabis Consumption
Drug Interactions
Cost Considerations
Addiction Risks
Suitability & Efficacy
Optimal Timing
THC/CBD Preference
Key Barriers to Adoption
Limited Clinical Education
Most physicians receive minimal training on medical cannabis during their education. Without evidence-based guidelines and clinical protocols, many hesitate to prescribe it despite patient interest.
Result: Physician uncertainty leads to conservative prescribing practices
Regulatory Complexity
Strict and fragmented regulatory frameworks across regions create significant barriers to entry for healthcare providers and organizations seeking to offer cannabis-based therapies.
Result: Reduced market competition and limited patient access
Patient Access Challenges
The combination of physician hesitancy and regulatory barriers means patients struggle to access personalized cannabis treatments, forcing continued reliance on conventional medications that may be less effective.
Result: Patients miss opportunities for improved symptom management
Critical Clinical Questions
Physicians and patients face numerous uncertainties when considering medical cannabis
Drug Interactions
How does cannabis interact with existing medications?
Cost Considerations
What is the cost-benefit ratio compared to conventional therapies?
Risk Assessment
What are the addiction and dependency risks?
Treatment Efficacy
Is it suitable and effective for this specific condition?
Optimal Timing
When is the best time to introduce cannabis therapy?
Product Selection
THC, CBD, or balanced formulations - which is appropriate?
How Leema.ai Addresses These Barriers
Ready to Overcome These Barriers?
Learn how Leema.ai can help your organization confidently integrate medical cannabis into elderly care